참고문헌
- Adelstein DJ, Li Y, Adams GL, et al (2003). An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemo-radiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol, 21, 92-8. https://doi.org/10.1200/JCO.2003.01.008
- Bernier J, Domenge C, Ozsahin M, et al (2004). Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med, 350, 1945-52. https://doi.org/10.1056/NEJMoa032641
- Brizel DM, Esclamado R (2006). Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol, 24, 2612-17. https://doi.org/10.1200/JCO.2005.05.2829
- Chan AT, Leung SF, Ngan RK, et al (2005). Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in loco-regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst, 6, 536-9.
- Cooper JS, Pajak TF, Forastiere AA, et al (2004). Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med, 350, 1937-44. https://doi.org/10.1056/NEJMoa032646
- Cox JD, Stetz J, Pajak TF (1995). Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys, 31, 1341-6. https://doi.org/10.1016/0360-3016(95)00060-C
- Forastiere AA, Goepfert H, Maor M, et al (2003). Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med, 349, 2091-98. https://doi.org/10.1056/NEJMoa031317
- Fountzilas G, Ciuleanu E, Dafni U, et al (2004). Concomitant radio-chemotherapy vs radiotherapy alone in patients with head and neck cancer. Med Oncol, 21, 95-107. https://doi.org/10.1385/MO:21:2:095
- Geeta SN, Padmanabhan TK, Samuel J, et al (2006). Comparison of acute toxicities of two chemotherapy schedules for head and neck cancers. J Cancer Res Ther, 2, 100-4. https://doi.org/10.4103/0973-1482.27584
- Gorodetsky R, Levy-Agababa F, Mou X, Vexler A (1998). Combination of cisplatin and radiation in cell culture: effect of duration of exposure to drug and timing of irradiation. Int J Cancer, 75, 635-42. https://doi.org/10.1002/(SICI)1097-0215(19980209)75:4<635::AID-IJC23>3.0.CO;2-6
- Gupta T, Agarwal JP, Laskar SG, et al (2009). Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience. Head Neck Oncol, 1, 17. https://doi.org/10.1186/1758-3284-1-17
- Homma A, Inamura N, Oridate N, et al (2011). Concomitant weekly cisplatin and radiotherapy for head and neck cancer. Jpn J Clin Oncol, 41, 980-6 https://doi.org/10.1093/jjco/hyr086
- Krstevska V, Stojkovski I, Zafirova-Ivanovska B (2012). Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors. Radiat Oncol, 7, 78 https://doi.org/10.1186/1748-717X-7-78
- Kumar S, Dimri K, Datta NR, et al (2002). Safety and efficacy of concurrent cisplatin and radiotherapy in inoperable or metastatic squamous cell esophageal cancer. Acta Oncologica, 41, 457-62. https://doi.org/10.1080/028418602320405050
- Kumar S, Dimri K, Khurana R, et al (2007). A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Radiother Oncol, 83, 139-47. https://doi.org/10.1016/j.radonc.2007.03.013
- Kumar S, Pandey M, Lal P, et al (2005). Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial. Radiother Oncol, 75, 186-92. https://doi.org/10.1016/j.radonc.2004.12.004
- Myint WK, Ng C, Raaphorst GP (2002). Examining the non-homologous repair process following cisplatin and radiation treatments. Int J Radiat oncol Biol, 78, 417-24. https://doi.org/10.1080/09553000110113047
- Otty Z, Skinner MB, Dass J, et al (2011). Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients. Asia Pac J Clin Oncol, 7, 287-92. https://doi.org/10.1111/j.1743-7563.2011.01405.x
- Pala M, Odrazka K, Holeckova P, et al (2012). Definitive radiochemotherapy with weekly cisplatin in patients with head and neck cancer; single institution outcome analysis. J BUON, 17, 471-7.
- Pignon JP, Bourhis J, Domenge C, Designe L (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet, 355, 949-55. https://doi.org/10.1016/S0140-6736(00)90011-4
- Pignon JP, Maitre AL, Bourhis J (2007). Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): An update. Int J Radiat Oncol Biol Phys, 69, 112-4.
- Rose PG, Bundy BN, Watkins EB, et al (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med, 15, 1144-53.
-
Steinmann D, Cerny B, Karstens JH, Bremer M (2009). Chemoradiotherapy with weekly cisplatin 40 mg/
$m^{2}$ in 103 head-and-neck cancer patients: a cumulative dose-effect analysis. Strahlenther Onkol, 185, 682-8. https://doi.org/10.1007/s00066-009-1989-5 - Watkins JM, Zauls AJ, Wahlquist AH, et al (2010). Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope, 120, 236-42. https://doi.org/10.1002/lary.21703
피인용 문헌
- Pu-erh Tea Powder Preventive Effects on Cisplatin-Induced Liver Oxidative Damage in Wistar Rats vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7389
- Whole-liver Radiotherapy Concurrent with Chemotherapy as a Palliative Treatment for Colorectal Patients with Massive and Multiple Liver Metastases: a Retrospective Study vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1597
- Protective Role of Selenium and High Dose Vitamin E against Cisplatin - Induced Nephrotoxicty in Rats vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.6877
- Weekly Cisplatin-Based Concurrent Chemoradiotherapy for Treatment of Locally Advanced Head and Neck Cancer: a Single Institution Study vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7309
- Concurrent Chemoradiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7331
- Survival in Head and Neck Cancers - Results of A Multi-Institution Study vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.1745
- Exclusive concurrent radiochemotherapy for advanced head and neck cancers with ‘fractionated’ 5-fluorouracil and cisplatin vol.28, pp.2, 2017, https://doi.org/10.1097/CAD.0000000000000440
- Tolerance of Chemoradiation in Advanced Head and Neck Cancers: Comparison Between Inpatients and Outpatients pp.0973-7707, 2017, https://doi.org/10.1007/s12070-017-1210-6